Alexandra M. Harrington, MD

Professor

view physician profile

Locations

Froedtert Hospital
Children's Wisconsin - Milwaukee
Froedtert Menomonee Falls Hospital
Pathology - Froedtert Hospital
Pathology - Children's

Specialties

Pathology - Anatomic
Pathology - Clinical
Hematopathology

Languages

English

Education

MD - Doctor of Medicine

Biography

Dr. Harrington's major responsibilities include hematopathology service work and instruction of medical students, residents, and fellows in hematopathology and coagulation. She oversees hematology and coagulation services for Wisconsin Diagnostic Laboratories at Froedtert Hospital/Medical College of Wisconsin. Dr. Harrington is also the Faculty Pillar Director for the Robert D. and Patricia E. Kem Institute for the Transformation of Medical Education at MCW, where she works on faculty development around medical education.

Research Interests

Flow cytometry of myeloid disorders

Plasma cell myeloma

Benign hematology disorders

Medical education

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.

(DeZern AE, Goll JB, Lindsley RC, Bejar R, Wilson SH, Hebert D, Deeg J, Zhang L, Gore S, Al Baghdadi T, Maciejewski J, Liu J, Padron E, Komrojki R, Saber W, Abel G, Kroft SH, Harrington A, Grimes T, Reed H, Fulton RS, DiFronzo NL, Gillis N, Sekeres MA, Walter MJ.) Blood Adv. 2023 Jul 25;7(14):3749-3759 PMID: 36947201 PMCID: PMC10368770 03/23/2023
How I Diagnose Mature T-Cell Proliferations by Flow Cytometry.

(Kroft SH, Harrington AM.) Am J Clin Pathol. 2022 Oct 06;158(4):456-471 PMID: 35929508 SCOPUS ID: 2-s2.0-85139572975 08/06/2022
Hemophagocytosis in cerebrospinal fluid after CAR T-cell therapy.

(Shah NN, Harrington AM.) Blood. 2022 Feb 17;139(7):1116 PMID: 35175320 SCOPUS ID: 2-s2.0-85124777621 02/18/2022
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome.

(Corrao K, Rezwan S, Atallah E, Michaelis LC, Runaas L, Harrington AM, Abedin S.) Leuk Res Rep. 2022;17:100329 PMID: 35651540 PMCID: PMC9150024 SCOPUS ID: 2-s2.0-85131561638 06/03/2022
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.

(Dhakal B, Sharma S, Balcioglu M, Shchegrova S, Malhotra M, Zimmermann B, Billings PR, Harrington A, Sethi H, Aleshin A, Hari PN.) Front Oncol. 2022;12:786451 PMID: 35186734 PMCID: PMC8848740 SCOPUS ID: 2-s2.0-85124893548 02/22/2022
Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient.

(Cardwell LA, Majerowski J, Chiu YE, Harrington AM, Sokumbi O.) J Cutan Pathol. 2021 May;48(5):706-712 PMID: 33476057 SCOPUS ID: 2-s2.0-85102302501 01/22/2021
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.

(Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS.) Leuk Lymphoma. 2021 Jan;62(1):158-166 PMID: 32951486 SCOPUS ID: 2-s2.0-85091139710 09/22/2020
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.

(Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN.) Biol Blood Marrow Transplant. 2020 Jul;26(7):1288-1297 PMID: 32135202 SCOPUS ID: 2-s2.0-85083636589 03/07/2020
Simple Laboratory Test Utilization Interventions to Reduce Inappropriate Specialty Coagulation Testing.

(Huang H, Cunningham AM, Harrington AM.) Am J Clin Pathol. 2020 Jan 02;153(2):181-189 PMID: 31602457 SCOPUS ID: 2-s2.0-85077403173 10/12/2019
Ancillary Studies in the Diagnostic Evaluation of Large B-Cell Lymphoma.

(Cunningham AM, Harrington AM.) Arch Pathol Lab Med. 2019 Dec;143(12):1464-1471 PMID: 31584842 SCOPUS ID: 2-s2.0-85075813941 10/05/2019
Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review.

(Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM.) Int J Lab Hematol. 2019 Feb;41(1):69-79 PMID: 30216684 SCOPUS ID: 2-s2.0-85053471510 09/15/2018
Daratumumab in Primary Effusion Lymphoma.

(Shah NN, Singavi AK, Harrington A.) N Engl J Med. 2018 Aug 16;379(7):689-690 PMID: 30110586 SCOPUS ID: 2-s2.0-85051817119 08/16/2018